PortfoliosLab logoPortfoliosLab logo
FIAC vs. AMLX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FIAC vs. AMLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Focus Impact Acquisition Corp. (FIAC) and Amylyx Pharmaceuticals, Inc. (AMLX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


FIAC

1D
1M
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*

AMLX

1D
-2.12%
1M
11.17%
6M
42.13%
YTD
68.13%
1Y
163.25%
3Y*
-4.58%
5Y*
10Y*
ALL TIME*
-0.73%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$41.59M$31.68M$25.94M

FIAC vs. AMLX - Yearly Performance Comparison


2026 (YTD)2025202420232022
FIAC
Focus Impact Acquisition Corp.
0.00%0.00%-81.54%6.97%3.14%
AMLX
Amylyx Pharmaceuticals, Inc.
68.13%219.58%-74.32%-60.16%75.95%

Correlation

The correlation between FIAC and AMLX is 0.01, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (3Y)
Balances recent behavior with more history.

0.00

Correlation (All Time)
Calculated using the full available price history since Jan 7, 2022

0.01

Fundamentals

Market Cap

FIAC:

$66.31M

AMLX:

$2.26B

EPS

FIAC:

-$1.26

AMLX:

-$1.51

Total Revenue (TTM)

FIAC:

$19.03K

AMLX:

$0.00

Gross Profit (TTM)

FIAC:

$6.16K

AMLX:

-$20.10M

EBITDA (TTM)

FIAC:

-$7.52M

AMLX:

-$150.30M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FIAC vs. AMLX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

FIAC

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


AMLX
AMLX Risk / Return Rank: 9393
Overall Rank
AMLX Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
AMLX Sortino Ratio Rank: 9393
Sortino Ratio Rank
AMLX Omega Ratio Rank: 8989
Omega Ratio Rank
AMLX Calmar Ratio Rank: 9595
Calmar Ratio Rank
AMLX Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

FIAC vs. AMLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Focus Impact Acquisition Corp. (FIAC) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FIACAMLXDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.35

Calmar ratioReturn relative to maximum drawdown

5.03

Martin ratioReturn relative to average drawdown

10.76

FIAC vs. AMLX - Sharpe Ratio Comparison


Loading charts...

Drawdowns

FIAC vs. AMLX - Drawdown Comparison


Loading charts...

Drawdown Indicators


FIACAMLXDifference

Max Drawdown

Largest peak-to-trough decline

-96.04%

Max Drawdown (1Y)

Largest decline over 1 year

-30.61%

Max Drawdown (3Y)

Largest decline over 3 years

-92.80%

Current Drawdown

Current decline from peak

-50.38%

Average Drawdown

Average peak-to-trough decline

-59.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.27%

Volatility

FIAC vs. AMLX - Volatility Comparison


Loading charts...

Volatility by Period


FIACAMLXDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.49%

Volatility (6M)

Calculated over the trailing 6-month period

39.64%

Volatility (1Y)

Calculated over the trailing 1-year period

61.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

90.71%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

90.71%

Dividends

FIAC vs. AMLX - Dividend Comparison

Neither FIAC nor AMLX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

FIAC vs. AMLX - Financials Comparison

This section allows you to compare key financial metrics between Focus Impact Acquisition Corp. and Amylyx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


FIAC and AMLX have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for FIAC and AMLX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer